At a glance
- Originator Mochida Pharmaceutical
- Class Anti-ischaemics; Antiarrhythmics; Decanoic acids; Hydroxy acids; Small molecules
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias